Furthermore, the mRNA levels of antimicrobial peptides, growth factors, and tight junction-related molecules, which are known to participate in the pathology of colitis (31–36) were comparable between the vehicle group and KNT-127-treated group, which may also be consistent with DOR deletion no affecting DSS-induced colon hypersensitivity. The gene discussed is OPRD1; the disease is colitis.